|
|
How do they add up? The interaction between the placebo and treatment effect: A systematic review
Rémy Boussageon
,
Jeremy Howick
,
Raphael Baron
,
Florian Naudet
,
Bruno Falissard
et al.
Journal articles
hal-03659749v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Comprendre le débat sur les antidépresseurs dans le traitement de l’épisode dépressif majeur [Understanding the Antidepressant Debate in the Treatment of Major Depressive Disorder]
Florian Naudet
,
Rémy Boussageon
,
Clément Palpacuer
,
Laurent Gallet
,
Jean-Michel Reymann
et al.
Journal articles
hal-01147040v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Projet Rebuild the Evidence Base
Hélène Vaillant-Roussel
,
Clara Blanchard
,
Thibault Menini
,
Elodie Charuel
,
Bruno Pereira
et al.
Journal articles
hal-04009951v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Quality of evidence of the efficacy of therapeutic interventions on patient-important outcomes in Cochrane's systematic reviews’ abstracts: A survey
Christine Maynié-François
,
Benoît Tudrej
,
Elodie Tawil
,
Florian Naudet
,
Caroline Huas
et al.
Journal articles
hal-02978547v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Has evidence-based medicine left quackery behind?
Florian Naudet
,
Bruno Falissard
,
Rémy Boussageon
,
David Healy
Journal articles
hal-01138648v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Vibration of effect in more than 16 000 pooled analyses of individual participant data from 12 randomised controlled trials comparing canagliflozin and placebo for type 2 diabetes mellitus: multiverse analysis
Henri Gouraud
,
Joshua D. Wallach
,
Rémy Boussageon
,
Joseph S. Ross
,
Florian Naudet
et al.
Journal articles
hal-04061254v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Project Rebuild the Evidence Base (REB): a method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients
Rémy Boussageon
,
Clara Blanchard
,
Elodie Charuel
,
Thibault Menini
,
Bruno Pereira
et al.
Journal articles
hal-03829199v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
An open science pathway for drug marketing authorization-Registered drug approval
Florian Naudet
,
Maximilian Siebert
,
Rémy Boussageon
,
Ioana A. Cristea
,
Erick H. Turner
et al.
Journal articles
hal-03330073v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
À propos de l’article : « Baclofène titré pour consommation à haut risque d’alcool »
Rémy Boussageon
,
Alain Braillon
,
Florian Naudet
,
Denis Pouchain
,
Catherine Cornu
et al.
Exercer, 2020, 166, pp.381-382
Journal articles
hal-03034372v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of acetylleucine in vertigo and dizziness: a systematic review of randomised controlled trials
Paul Vanderkam
,
Clara Blanchard
,
Florian Naudet
,
Denis Pouchain
,
Hélène Vaillant Roussel
et al.
Journal articles
hal-01978421v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate
Clément Palpacuer
,
Renan Duprez
,
Alexandre Huneau
,
Clara Locher
,
Rémy Boussageon
et al.
Journal articles
hal-01696955v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials
Clément Palpacuer
,
Bruno Laviolle
,
Rémy Boussageon
,
Jean Michel Reymann
,
Eric Bellissant
et al.
Journal articles
hal-01255842v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|